DRL's management has guided for double-digit growth in FY26, with margins expected to remain similar to FY25 levels. Here's ...

Discover why Dr. Reddy’s Laboratories remains a strong buy amid robust revenue growth, underappreciated pipeline potential, ...

Emkay's latest report downgrades Dr. Reddy's Labs, citing significant margin misses in Q4FY25 despite higher other income and lower tax rates.

We are currently an enrolling site for a multi-center clinical trial, Abatacept in Immune Checkpoint Inhibitor Myocarditis (ATRIUM). The purpose of this trial is to understand and explore treatment ...

President Trump touted a new Executive Order that would more closely align drug prices in the US with those sold in Europe ...

The EULAR updated their recommendations for antirheumatic drug use among patients with RMDs during pregnancy and fertility ...

Hyderabad: Dr Reddy's Laboratories Limited has informed in a BSE filing that Dr Reddy's Laboratories SA, Switzerland, a ...

May 1, 2025 — After spending years tracing the origin and migration pattern of an unusual type of immune cell in mice, researchers have shown in a new study how activity of 'good' microbes in ...

Medically healthy survivors of the 1995 Oklahoma City bombing had significantly different biological stress measures compared with adults who did not experience the bombing, years after it ...

The metabolic score for insulin resistance effectively predicted cardiovascular events among patients with psoriatic arthritis over a 10-year period. Recent study results published in RMD Open suggest ...